Dyadic International
Price & Volume
Stats
See more52W Range | $0.92-$2.67 |
Market Cap | $29M |
Shares Short | 121,995 |
Financials
See moreRevenue (12 Mos) | $1.8M |
Revenue Growth (YoY) | -53.9% |
Gross Profit (12 Mos) | $807,110 |
Diluted EPS | -$0.27 |
News
See moreYahoo Finance • 10 months ago
Dyadic Attends Investor Events in December
Yahoo Finance • 10 months ago
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Yahoo Finance • 11 months ago
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
Yahoo Finance • 11 months ago
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
About
CEO | Mr. Mark A. Emalfarb |
Address | 1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |
